How to define treatment success using cholinesterase inhibitors
- 11 April 2002
- journal article
- research article
- Published by Wiley in International Journal of Geriatric Psychiatry
- Vol. 17 (4) , 388-390
- https://doi.org/10.1002/gps.612
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- A 1-year, placebo-controlled preservation of function survival study of donepezil in AD patientsNeurology, 2001
- A 1-year, randomized, placebo-controlled study of donepezil in patients with mild to moderate ADNeurology, 2001
- Pharmacotherapy of Alzheimer's disease: is there a need to redefine treatment success?International Journal of Geriatric Psychiatry, 2001
- A 1-year multicenter placebo-controlled study of acetyl-L-carnitine in patients with Alzheimer's diseaseNeurology, 1996
- A 30-Week Randomized Controlled Trial of High-Dose Tacrine in Patients With Alzheimer's DiseaseJAMA, 1994
- A longitudinal study of Alzheimer's disease: measurement, rate, and predictors of cognitive deteriorationAmerican Journal of Psychiatry, 1994
- A Double-Blind, Placebo-Controlled Multicenter Study of Tacrine for Alzheimer's DiseaseNew England Journal of Medicine, 1992
- Oral Tetrahydroaminoacridine in Long-Term Treatment of Senile Dementia, Alzheimer TypeNew England Journal of Medicine, 1986